• Return to Headlines

Nektar Therapeut Shares Down 44.9% Since SmarTrend's Sell Call (NKTR)

By James Quinn

SmarTrend identified a Downtrend for Nektar Therapeut (NASDAQ:NKTR) on July 17th, 2019 at $32.33. In approximately 4 weeks, Nektar Therapeut has returned 44.90% as of today's recent price of $17.81.

Nektar Therapeut share prices have moved between a 52-week high of $69.76 and a 52-week low of $17.50 and are now trading 2% above that low price at $17.81 per share. Over the last five market days, the 200-day moving average (MA) has gone down 0.8% while the 50-day MA has declined 2.4%.

Nektar Therapeutics, a research-based biopharmaceutical company, discovers and develops drug candidates for cancer, auto-immune disease, and chronic pain in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Nektar Therapeut.

Log in and add Nektar Therapeut (NKTR) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights nektar therapeut

Ticker(s): NKTR